Loading
Enhanced Group Inc. Stock: price and insider trades · United States
US·Mcap US$498.5M
1 insider bought €9.6M of shares over the last 90 days, the latest filed 21 Sept 2026.
Enhanced Group Inc.: what insiders have been doing
Every trade that managers of Enhanced Group Inc. disclose to SEC (Form 4) is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 17 filings came from 4 insiders.
No insider sold shares on the market over the period. Instead, the filings list 11 purchases totalling €9.6M, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 senior executive. At €6.1M, the purchase published on 21 September 2026 by Apeiron Investment Group Ltd. is the largest of the period (1.2% of market cap).
Compared with its exchange (5,458 companies, median 22 filings), a count of 17 filings is below the norm. Looking back to 2025, when coverage begins, insiders filed 13 purchases and no sales.
The clock since the last published purchase (21 September 2026) now reads 26 days. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
19
Thresholds
n/a
Buy Volume
€10M
13 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleApeiron Investment Group Ltd.11 buys
ASPAC IV (Holdings) Corp.1 buy
Claudius Tsang1 buy
Since the insiders bought
- -21.8%Entry US$1.56 · Close 16 Oct 2026 US$1.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.26
Analyst consensus
3 analysts1.00/5
US$3.00Target US$4.00(+217%)US$5.00
Income statement
EBITDA-US$26.9M
Net income-US$26.7M0.0% margin
Valuation
PER (forward)-18.9x
P/Book52.5x
Balance sheet & cash
Market capUS$498.5M
Free Cash Flow-US$24.8M
Profitability & ownership
% insiders54.8%
% institutions40.5%
Last declaration on 21 September 2026
Declarations19 total
6,080,047 shares@ US$1.151.22% mcap63.5% of flowClass A Common StockSEC:0001193125-26-397056:0
Canonical exit: 16 Dec 2026 (T+90)
59,337 shares@ US$1.56860.016% mcap0.8% of flowClass A Common StockSEC:0001193125-26-386771:1
Canonical exit: 7 Dec 2026 (T+90)
21,034 shares@ US$1.61160.0058% mcap0.3% of flowClass A Common StockSEC:0001193125-26-386771:0
Canonical exit: 3 Dec 2026 (T+90)
99,342 shares@ US$1.60430.027% mcap1.4% of flowClass A Common StockSEC:0001193125-26-386771:2
Canonical exit: 8 Dec 2026 (T+90)
107,693 shares@ US$1.57510.029% mcap1.5% of flowClass A Common StockSEC:0001193125-26-383717:0
Canonical exit: 1 Dec 2026 (T+90)
25,414 shares@ US$1.57990.0069% mcap0.4% of flowClass A Common StockSEC:0001193125-26-383717:1
Canonical exit: 2 Dec 2026 (T+90)
2,120,823 sharesClass A Common StockSEC:0001193125-26-357979:0
55,000 shares@ US$1.64330.016% mcap0.8% of flowClass A Common StockSEC:0001193125-26-357979:3
Canonical exit: 17 Nov 2026 (T+90)
93,000 shares@ US$1.70120.027% mcap1.4% of flowClass A Common StockSEC:0001193125-26-357979:1
Canonical exit: 16 Nov 2026 (T+90)
1,619,316 shares@ US$1.660.46% mcap24.2% of flowClass A Common StockSEC:0001193125-26-357979:2
Canonical exit: 17 Nov 2026 (T+90)
1,285,347 sharesClass A common stockSEC:0001628280-26-057808:0
200,000 shares@ US$1.65210.057% mcap3.0% of flowClass A Common StockSEC:0001193125-26-354788:0
Canonical exit: 15 Nov 2026 (T+90)
150,000 shares@ US$1.97080.051% mcap2.7% of flowClass A Common StockSEC:0001193125-26-353161:0
Canonical exit: 12 Nov 2026 (T+90)
3,020,565 sharesClass A Common StockSEC:0001193125-26-316451:0
7,116,667 sharesClass A common stockSEC:0001213900-26-056175:0
10,151,943 sharesClass A common stockSEC:0001628280-26-033762:0
6,020,814 sharesClass A common stockSEC:0001628280-26-033760:0
400,000 sharesClass A ordinary sharesSEC:0001213900-25-070032:0
Canonical exit: 29 Oct 2025 (T+90)
400,000 sharesClass A ordinary sharesSEC:0001213900-25-070033:0
Canonical exit: 29 Oct 2025 (T+90)
19 of 19 declarations
About Enhanced Group Inc.
Enhanced Group Inc. (ticker: ENHA) is a U.S.-listed company that began trading on the NYSE in May 2026 after completing its business combination with A Paradise Acquisition Corp. The company is headquartered at 169 Madison Avenue, Suite 15101, New York, NY 10016, and its SEC filings and corporate communications place it firmly in the United States market. For investors, ENHA is not a traditional industrial or consumer staple story; it is a highly unusual growth platform positioned at the intersection of sports entertainment, performance technology, and wellness.
The business is built around two core pillars. First, the “Enhanced Games,” a new global sports competition and media property designed to showcase elite athletic performance through a science- and technology-led narrative. Second, “Live Enhanced,” a consumer-facing subscription and product platform focused on performance, recovery, vitality, and longevity. The company also describes a premium line of science-backed products and telehealth-supported protocols, broadening the model beyond a one-off sporting event into a recurring consumer ecosystem.
Read moreShow less
Enhanced was founded in 2023 by Australian entrepreneur Aron D’Souza. Over time, the leadership structure has evolved, with Maximilian Martin serving as CEO and Christian Angermayer as Executive Chairman. That combination gives the company a mix of operating, consumer-brand, and capital-markets experience. The group’s public messaging emphasizes medical oversight, evidence-based research, transparency, and responsible protocols, which it uses to differentiate itself in a highly controversial and closely watched category.
From a competitive standpoint, Enhanced occupies a niche with limited direct comparables. It competes indirectly with established sports organizations, streaming and media platforms, sports marketing businesses, and the broader health-and-wellness category. Its potential advantage lies in brand differentiation and in the ability to monetize multiple revenue streams: live events, sponsorships, content distribution, consumer products, and digital or telehealth-enabled services. Recent company announcements have highlighted distribution partnerships and content deals around the 2026 Enhanced Games, as well as product-line expansion, suggesting an effort to turn the brand into a broader platform rather than a single-event franchise.
That said, the investment case remains highly speculative. The company has a limited operating history, limited disclosed financial scale, and significant execution risk. Its future performance will likely depend on audience acceptance, athlete recruitment, sponsor demand, financing access, and ongoing regulatory and reputational scrutiny. In short, ENHA on the NYSE in the United States is best viewed as a narrative-driven growth equity with high optionality and correspondingly high risk, rather than a mature, fundamentals-led business.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
